| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-12 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-12 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-11 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-11 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.22 | 9e-11 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-10 |